Zoltan Ungvari to Proto-Oncogene Proteins c-bcl-2
This is a "connection" page, showing publications Zoltan Ungvari has written about Proto-Oncogene Proteins c-bcl-2.
Connection Strength
0.182
-
Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice. Geroscience. 2021 10; 43(5):2427-2440.
Score: 0.182
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.